Meeting Banner
Abstract #0551

Comparison of TRUS Vs. MRI Guided Biopsy in MRI Apparent Prostate Cancers: Preliminary Results

Adam J. Jung1, Fergus V. Coakley2, Antonio C. Westphalen3, Daniel B. Vigneron3, John Kurhanewicz

1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA , United States; 2Department of Radiology and Biomedical Imaging, University of California San Francisco; 3Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States

The primary socioeconomic challenge in caring for patients with prostate cancer is our limited ability to accurately characterize the disease as indolent or aggressive at the time of presentation, and stratify management from active surveillance through definitive surgery or radiation accordingly. A major contributing factor to this problem is the known inaccuracy in disease detection and characterization by systematic transrectal ultrasound-guided biopsy, even though this is the current standard of care for diagnosis. We demonstrate that multiparametric MRI supplemented by MRI-guided biopsy can improve both disease detection and characterization, and may ultimately improve our ability to deliver personalized patient care in men with prostate cancer.

Abstract PDF Presentation Video

Keywords

abnormal accordingly accurately active aggressiveness agreed alone alter apparent benign better biomedical biopsied biopsies biopsy blinded cancer cancers cause characteristic characterizing clear clearly cohorts commonest commonly considered contrast core cores correlated criteria critical death decision degree demonstrating depend dependent depict depicted diagnosis dictate diffusion direct dynamic error evaluated experienced extent false findings flawed focus glandular grade guided identification improve indicate indicating initial invariably invasive largely least lesions localization localize localizes location logical malignant management maps metabolic mode needle negative next offers often operating overall paradigm pathology patient patients percentage perfusion poor positive possibly post potential presence prior prognosis prospective prostate quart radiology receiver recent recommendation regarding relatively remaining repeat reported respectively restriction retrospective reviewed risk sample samples sampling schemes score scores significantly slightly specimen specimens spectroscopic spectroscopy staging step stratification studies subsequent subsequently substantiated surveillance suspicious systematically tissue treatment trials tumor turn ultrasound upgrade upgraded urology versus visible visualize volume watchful